List view / Grid view
Antibiotics are a type of antimicrobial drug used in the treatment and prevention of bacterial infections.
15 September 2015 | By
Since initiating the project in 2014, significant progress has been made towards the invention of new compounds with activity against both gram-positive and gram-negative bacteria...
14 September 2015 | By Victoria White
The potential new antibiotics are unlike contemporary antibiotics because they contain iridium, a silvery-white transition metal...
7 September 2015 | By Victoria White
Basilea is to work with the iABC consortium to develop an inhaled formulation of its antibiotic BAL30072 as part of a new Europe-wide programme...
3 September 2015 | By Victoria White
The University of Brighton has announced it is sharing in a €5.9m EU grant to support the development of a new treatment for chronic liver disease...
2 September 2015 | By Victoria White
ESCMID advocates the need for greater education, guidance and research on the build-up, treatment and prevention of biofilms...
24 August 2015 | By Victoria White
Motif Bio has announced the topline results of an independent report that show iclaprim is effective in vitro against a range of Gram-positive bacteria...
21 July 2015 | By
Researchers have now shown that a “messenger molecule” produced by P. aeruginosa encourage bacteria to colonise catheters, forming a biofilm...
30 June 2015 | By Victoria White
Scientists have unravelled a key process in the bacterium that causes TB, potentially paving the way for new antibiotics to fight the disease...
16 June 2015 | By Victoria White
Marks & Blerk’s latest report highlights the striking difference between research levels into rare diseases, vaccines and antibiotics across the globe...
11 June 2015 | By Victoria White
The European Society of Clinical Microbiology and Infectious Diseases has launched a new study group: the Forensic and Postmortem Microbiology Study Group...
9 June 2015 | By Victoria White
Researchers have identified the molecular docking site that is responsible for C. difficile toxins being able to bind to a receptor...
3 June 2015 | By Victoria White
Auspherix has raised £6 million in a Series A venture financing and is establishing operations on the Stevenage Bioscience Catalyst site...
2 June 2015 | By Victoria White
MGB Biopharma has developed a stable IV formulation of MGB-BP-3 for the treatment of Gram-positive hospital-acquired infections...
21 May 2015 | By Victoria White
Researchers have developed a second-generation of spectinomycin that shows early effectiveness against common bacterial infections...
19 May 2015 | By Victoria White
Researchers have discovered a key cause of life threatening heart complications, conditions that frequently follow severe Streptococcus pneumoniae infection..
